Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Long-Term Peg Intron Vs. Colchicine in Non-Responders.
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005
by Beth Israel Deaconess Medical Center.
Recruitment status was Active, not recruiting
Study NCT00179413 Information provided by Beth Israel Deaconess Medical Center
First Received on September 10, 2005. Last Updated on June 23, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hepatitis C Virus
Advanced Fibrosis
Cirrhosis
Additional conditions recognized in this trial
Fibrosis
Hepatitis
Hepatitis A
Hepatitis C
Liver Cirrhosis
More general conditions related to this trial
Digestive System Diseases
Enterovirus Infections
Flaviviridae Infections
Hepatitis, Viral, Human
Liver Diseases
Pathologic Processes
Picornaviridae Infections
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
PEG interferon Alfa-2b; Colchicine
Additional drug interventions recognized in this trial
Colchicine
Interferon Alfa-2a
Interferon Alfa-2b
Interferon-alpha
Interferons
Peginterferon alfa-2b
Reaferon
More general drug interventions related to this trial
Adjuvants, Immunologic
Alcohol Deterrents
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Anti-Infective Agents
Antimitotic Agents
Antineoplastic Agents
Antirheumatic Agents
Antiviral Agents
Central Nervous System Agents
Gout Suppressants
Growth Inhibitors
Growth Substances
Immunologic Factors
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Beth Israel Deaconess Medical Center
Schering-Plough
Back to top of Main Content